Invention Grant
- Patent Title: Combination therapy with glutaminase inhibitors
-
Application No.: US15685566Application Date: 2017-08-24
-
Publication No.: US10195197B2Publication Date: 2019-02-05
- Inventor: Mark K. Bennett , Matthew I. Gross , Susan D. Bromley , Keith Orford
- Applicant: Calithera Biosciences, Inc.
- Applicant Address: US CA South San Francisco
- Assignee: Calithera Biosciences, Inc.
- Current Assignee: Calithera Biosciences, Inc.
- Current Assignee Address: US CA South San Francisco
- Agency: Foley Hoag LLP
- Agent David P. Halstead
- Main IPC: A61K31/41
- IPC: A61K31/41 ; A61K31/335 ; A61K31/501 ; A61K31/337 ; A61K45/06 ; A61K31/138 ; A61K31/38 ; A61K31/4196 ; A61K31/433 ; A61K31/454 ; A61K31/513 ; A61K31/555 ; A61K31/675 ; A61K31/69 ; A61K31/704
Abstract:
The invention relates to novel heterocyclic compounds and pharmaceutical preparations thereof. The invention further relates to methods of treating or preventing cancer using the novel heterocyclic compounds of the invention.
Public/Granted literature
- US20180055842A1 Combination Therapy with Glutaminase Inhibitors Public/Granted day:2018-03-01
Information query
